Cite
HARVARD Citation
Weinblatt, M. et al. (n.d.). THU0193 Response To Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies. Annals of the rheumatic diseases. pp. 255-256. [Online].